Noradrenaline and isoproterenol kinetics using intravenous infusion of L-3H-NA and of 3H-isoproterenol were investigated in eight Type I (insulin-dependent) diabetic patients without neuropathy and in eight Type 1 diabetic patients with autonomic neuropathy matched for age, sex and duration of diabetes. Resting plasma noradrenaline and adrenaline concentrations were reduced in patients with autonomic failure (p < 0.05). The metabolic clearance rate of noradrenaline was similar in both groups of patients, and the appearance rate of noradrenaline in plasma was reduced in patients with autonomic failure (p < 0.01). The disappearance of L-3H -noradrenaline from plasma after the infusion of L-3H-noradrenaline had been stopped was not different in patients with and without neuropathy. The metabolic clearance of isoproterenol was not influenced by the presence of autonomic failure and mean values were similar to the corresponding values for noradrenaline. Isoproterenol was only taken up by a non-neuronal uptake; this finding may indicate that neuronal uptake is not important for the inactivation of circulating catecholamines. Alternatively, because the non-neuronal uptake of isoproterenol is probably greater than that of noradrenaline, we cannot exclude the possibility that a small decrease in the neuronal uptake of noradrenaline was compensated for by a slightly higher non-neuronal uptake.
Plasma noradrenaline (NA) is widely used as an index for sympathetic nervous system activity in man, and represents the net result of release and re-uptake in sympathetic nerve endings and non-neuronal removal from the plasma. In chronic autonomic failure plasma NA is usually low, but may be within normal range [1] [2] [3] [4] [5] . Conflicting results have been reported with regard to the metabolic clearance rate in patients with autonomic failure. Esler et al. [6] found in four patients with idiopatic autonomic failure that both the plasma NA appearance rate and the clearance rate were reduced, resulting in near normal plasma concentrations of NA. In addition, the disappearance rate of NA after the infusion was stopped was found to be lower than in normal controls [7] . Hoeldtke et al. [10] found in diabetic patients with autonomic failure that the metabolic clearance rate was unchanged. The aim of the present study was to elucidate these conflicting observations. We also investigated the metabolic clearance rate of isoproterenol to examine the extent to which circulating catecholamines are cleared by non-neuronal mechanisms [8] .
Subjects and methods

Subjects
Sixteen Type I (insulin-dependent) diabetic patients participated in the study after informed consent. Clinical data are given in Table 1 . Eight patients had signs of autonomic neuropathy judged by a decreased heart rate response to deep breathing (< 10beats/rain) and orthostatic hypotension defined as a drop in systolic blood pressure of more than 30 mmHg upon standing up.
Likewise, these patients had signs of peripheral neuropathy judged by increased vibratory perception threshold in the big toe, measured by a Biothesiometer (Biomedical Instruments Co, Ohio Neubury, USA) and absent tendon reflexes. The thresholds are expressed in volts, with a threshold value of 20 V being indicative of neuropathy. All patients had retinopathy (6proliferative, 2back-ground). Six patients had proteinuria; of these, four had elevated serum creatinine.
Eight Type 1 diabetic patients without any signs of neuropathy matched for sex, age and duration of diabetes were examined as controls. Four of these had retinopathy (all background) and none had any signs of diabetic nephropathy.
Apart from diabetes and diabetic complications, the patients had no other known disease. Two of the patients with autonomic neuropa- 
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r~ thy were taking thiazides for a mild hypertension and the other patients took no drugs. The study was approved by the local Ethical Committee.
Methods
Each patient participated in three experiments. All were carried out in the supine position, after 30 rain of rest, in random order. All experiments were performed between 15.00 and 17.00hours. The patients were not allowed to smoke or eat within 3 h prior the study. All patients had taken their usual dose of insulin before breakfast, but none had insulin at noon. In the first experiment an intravenous infusion of L-3H-NA (specific activity 15 Ci/mmol) was given in a dose of 0.35 ~tCi/min/m 2 body surface for 90 min. Before each infusion the L-3H-NA was diluted with saline to a total volume of 50 ml. The infusion was given through an indwelling catheter in an antecubital vein, and venous blood samples of 8 ml were taken before the start of infusion from a catheter placed in the contralateral arm. Venous blood samples for the determination of NA kinetics were drawn after 75 and 90 min of L-3H-NA infusion. Arterial blood samples of 8 ml were obtained by puncture of the femoral or radial artery at 90 min. Plasma glucose was measured immediately before the start of infusion and at 60 min. Arterial blood pressure and heart rate were measured before and 75 min after the start of infusion.
In the second study an infusion of 3H-isoproterenol (specific activity 15 Ci/mmol) was given at a dose of 0.35 ~tCi/min/m 2 body surface for 90 min. Venous and arterial blood samples were drawn as on the first day of the examination. The two experiments were carded out at an interval of up to 5 weeks.
To investigate venous plasma NA disappearance rate, an infusion of L-3H-NA (specific activity 15 Ci/mmol) was given at a dose of 0.70 IxCi/min/m 2 body surface for 75 min in an antecubital vein. From a catheter placed in the contralateral arm, venous blood samples of 16 ml were obtained before the start of infusion, at 30, 60 and 75 min during the infusion and at 1, 2, 3, 5,10, 20, and 30 min after the cessation of infusion.
Assays
All blood samples and aliquots of the infusate before and after infusion were collected in tubes with 20 ~tl/ml blood or infusate of a mixture of 95 mg EGTA and 60 mg reduced glutathione in 1 ml water. NA and adrenaline were measured by a single-isotope derivative assay [9] . Coefficient of variation calculated on the basis of duplicated determinations was 11% for adrenaline and 7% for NA. Tritium labelled NA and isoproterenol in plasma were determined as described earlier [11] . Haemoglobin Ale was determined by thinlayer isoelectric focusing; in our laboratory normal range is 4.1-6.1%, with a between assay coefficient of variation of 4%.
Calculations
Clearance (1/min) was calculated as L-3H-NA infusion dose dpm/ min divided by L-3H-NA plasma concentration (dpm/1).
Forearm extraction ratio
Ca -Cv/Ca where Ca and Cv are L-3H-NA or (3H) isoprenaline counts in arterial (a) and venous (v) blood respectively.
Appearance rate (~xg/min)
Plasma concentrations of NA (Ixg/1) multiplied by the clearance of NA (1/min). 
Statistical analysis
The Mann-Whitney rank sum test for unpaired data was used. P values less than 5% were considered statistically significant.
Results
Resting plasma concentrations of NA and adrenaline were significantly lower in Type 1 diabetic patients with autonomic neuropathy compared to patients without neuropathy (p < 0.05, Table 2 ). Plasma clearance of NA based on arterial sampling was similar in the two groups and similar to values previously observed in control subjects [11] [12] [13] . Autonomic neuropathy had no effect on the clearance of isoproterenol, which was similar to that of NA in both patient groups. (Table 3 ). The appearance rate of NA was significantly lower in patients with autonomic neuropathy as compared to patients without neuropathy (Fig. 1, p < 0.05) .
The disappearance rate of L-3H-NA after the infusion was stopped was not different in patients with and without autonomic neuropathy (p > 0.1 for all point of measurements) (Fig. 2) . Finally, the arterial-venous difference of isoproterenol and of NA in the forearm was not significantly different comparing both groups of patients. No side effect of the infusion was seen. Neither heart rate nor arterial blood pressure changed significantly during the infusion of L-3H-NA or 3H-isoproterenol.
when calculations were based on venous rather than on arterial blood sampling, but this difference was not significant (Table 3) . It should be emphasized that the NA disappearance rate was also similar in diabetic patients with and without autonomic neuropathy, in contrast to the findings in patients with primary autonomic failure. Finally, the arterial-venous difference of isoproterenol and of NA in the forearm was not significantly different between the two groups of patients and in fact similar in the individual group.
Some limitations of the methods of measuring NA kinetics must be emphasized. When venous infusion of L-3H-NA is employed, steady state concentrations of L-3H-NA should preferably be sampled in the mixed venous blood in the pulmonary artery. Arterial sampling may be used, however, because recent studies have shown that there is a relatively small extraction of NA in the pulmonary artery (approximately 7%) and no release of NA. The calculation of the clearance rate of NA using arterial sampling may therefore be overestimated by approximately 7% [14] .
Another problem with the measurement of NA clearance is that one cannot be sure that the specific activity of NA in plasma is the same as at the break-down sites. Thus, the calculated clearance of NA may probably best be viewed as a relative index of the clearance of NA.
Interestingly, the clearance of isoproterenol and NA was the same despite the fact isoproterenol is only taken up by a non-neuronal uptake (methylation) [8] . These findings may indicate that neuronal uptake is not important for the inactivation of circulating catecholamines. It is more likely, however, that extraneuronal uptake of isoproterenol is greater than that of NA [15, 16] . We cannot exclude the possibility that a relatively small decrease in neuronal uptake of NA in patients with diabetic autonomic neuropathy was outweighed by a slightly higher non-neuronal uptake. Finally, it should be noted that, in our calculation, we did not take into account the possible influence of the capillary bartier on the clearance rate.
Discussion
Our results indicate that the reduced levels of plasma NA in Type I diabetic patients with autonomic failure is due to a decreased plasma appearance rate and not due to changes in metabolic clearance rate. These findings are in accordance with observations by Hoeldtke et al.
[10], and in contrast to the findings reported by Esler et al. [6] . In both the above mentioned studies, steady state concentration of L-3H-NA was obtained from venous sampling. Because of peripheral uptake of NA, which may be influenced by individual variations, clearance determination must be based on arterial rather than venous blood samples [11] . In accordance with this, we found a tendency for lower clearance values at 75 min
